POCI Precision Optics Corporation, Inc.
Healthcare$4.97+0.81%ClosedMarket Cap: $38.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.91
P/S
1.32
EV/EBITDA
-7.06
DCF Value
$-21.08
FCF Yield
-4.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
13.8%
Operating Margin
-16.4%
Net Margin
-17.0%
ROE
-37.5%
ROA
-14.6%
ROIC
-19.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $8.7M | 23.6% | $-64.5K | $-108.3K | $— | — |
| Q2 null | $7.4M | 2.8% | $-1.7M | $-1.8M | $— | — |
| Q1 null | $6.7M | 14.2% | $-1.6M | $-1.6M | $— | — |
| Q4 null | $6.2M | 12.9% | $-1.4M | $-1.4M | $— | — |
| FY null | $19.1M | 17.8% | $-5.6M | $-5.8M | $— | — |
| Q3 null | $4.2M | 10.0% | $-2.0M | $-2.1M | $— | — |
| Q2 null | $4.5M | 23.6% | $-910.0K | $-969.7K | $— | — |
| Q1 null | $4.2M | 26.6% | $-1.2M | $-1.3M | $— | — |
| Q4 null | $4.7M | 21.7% | $-1.4M | $-1.4M | $— | — |
| FY null | $19.1M | 30.3% | $-2.7M | $-3.0M | $— | — |
| Q3 null | $5.2M | 35.5% | $-258.5K | $-317.1K | $— | — |
| Q2 2024 | $4.8M | 30.1% | $-704.2K | $-758.8K | $-0.13 | — |